Cooper Companies Director Kurzius Buys $549,300 in Shares. Is the Eye Care Stock About to Rally?
Key PointsThe director acquired 10,000 shares at $54.93 per share, representing a total investment of $549,300.
Lawrence Erik Kurzius, a director at The Cooper Companies, Inc. (COO), bought 10,000 shares of the company's common stock on September 16, 2026, according to a recent SEC Form 4 filing. The transaction was valued at $549,300, based on a weighted average purchase price of $54.93 per share. At the market close on that day, the stock was trading at $54.61 per share, representing a slight decrease from the weighted average purchase price.
The Cooper Companies, a global medical device manufacturer, operates in two segments: contact lenses and specialized surgical and women's health products. The company employs approximately 15,000 people and boasts a market capitalization of $10.4 billion. Over the trailing twelve months, the company generated $4.2 billion in revenue.
Strategically, Cooper Companies has positioned itself as a major player in the ophthalmic medical device market through its commitment to innovation in vision correction and myopia management. The company's existing distribution network further strengthens its market presence. Kurzius' recent purchase of shares may be an indication of his confidence in the company's future performance.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
